dehydroepiandrosterone has been researched along with em 800 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Bélanger, A; Labrie, C; Labrie, F; Luo, S; Sourla, A | 1 |
| Labrie, C; Labrie, F; Martel, C; Sourla, A | 1 |
| Bélanger, A; Candas, B; Couillard, S; Labrie, C; Labrie, F; Pouliot, F | 1 |
| Fournier, M; Labrie, C; Labrie, F; Li, S; Martel, C; Pelletier, G; Picard, S; Sourla, A; Stojanovic, M | 1 |
| Labrie, C; Labrie, F; Richard, V; Sourla, A | 1 |
6 other study(ies) available for dehydroepiandrosterone and em 800
| Article | Year |
|---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Combined effects of dehydroepiandrosterone and EM-800 on bone mass, serum lipids, and the development of dimethylbenz(A)anthracene-induced mammary carcinoma in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaline Phosphatase; Animals; Benzopyrans; Bone Density; Calcium; Carcinogens; Cell Transformation, Neoplastic; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Female; Genitalia, Female; Lipids; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Phosphorus; Prolactin; Propionates; Random Allocation; Rats; Rats, Sprague-Dawley | 1997 |
Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland.
Topics: Androgen Antagonists; Androgens; Animals; Benzopyrans; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Flutamide; Mammary Glands, Animal; Medroxyprogesterone; Ovariectomy; Propionates; Rats; Rats, Sprague-Dawley | 1998 |
Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Benzopyrans; Breast Neoplasms; Dehydroepiandrosterone; Drug Administration Schedule; Estrogen Antagonists; Estrone; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Ovariectomy; Propionates; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Predominant androgenic component in the stimulatory effect of dehydroepiandrosterone on bone mineral density in the rat.
Topics: Androgen Antagonists; Animals; Benzopyrans; Bone Density; Cholesterol; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Femur; Flutamide; Medroxyprogesterone Acetate; Ovariectomy; Progesterone Congeners; Propionates; Rats; Rats, Sprague-Dawley; Stimulation, Chemical | 1998 |
Exclusive androgenic effect of dehydroepiandrosterone in sebaceous glands of rat skin.
Topics: Administration, Cutaneous; Androgen Antagonists; Animals; Benzopyrans; Dehydroepiandrosterone; Estrogen Receptor Modulators; Female; Flutamide; Hyperplasia; Models, Animal; Ovariectomy; Propionates; Random Allocation; Rats; Rats, Sprague-Dawley; Sebaceous Glands; Stimulation, Chemical; Time Factors | 2000 |